| NCT01129596Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease- | Donepezil Alzheimer’s disease | Alzheimer's disease | Not applicable | Completed | 722 | Sep 2015 | 1 | |
| REFLECT-2Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease | Donepezil, Rosiglitazone Alzheimer’s disease | mild-to-moderate AD | Not applicable | Completed | 249 | Jan 2009 | 1 | results |
| MAyflOwer RoADA Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy | Donepezil, Galantamine, Memantine, Rivastigmine, RO4602522 Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 142 | Jun 2015 | 1 | |
| NCT01251718Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease | Donepezil Alzheimer’s disease | Age ≥18 | Not applicable | Completed | 106 | Oct 2015 | - | |
| NCT00710684A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease | Donepezil, Intepirdine Alzheimer’s disease | mild-to-moderate AD | Ph 2 | Completed | 102 | May 2010 | 1 | results |
| NCT00895895Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease | Donepezil, SAM-531 Alzheimer’s disease | Alzheimer's disease | Ph 2 | Terminated | 96 | May 2011 | - | results |
| NCT01266525Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil | Donepezil, SAR110894 Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 82 | Jan 2013 | 2 | |
| NCT00708552Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease | Donepezil, Intepirdine Alzheimer’s disease | mild-to-moderate AD | Ph 2 | Completed | 72 | Mar 2010 | 1 | results |
| NCT00000173Memory Impairment Study (Mild Cognitive Impairment Study) | Donepezil Alzheimer’s disease, MCI / preclinical Alzheimer’s | Alzheimer's disease | Ph 3 | Completed | 72 | Jan 2004 | 9 | |
| NCT02580305SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study | Donepezil, Masupirdine, Memantine Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 71 | Nov 2019 | 3 | results |
| SiroccoProof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease | AZD3480, Donepezil Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 70 | Aug 2008 | - | |
| NCT00165659A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020 | Donepezil Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 65 | May 2005 | - | |
| NCT02337907BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. | BI 409306, Donepezil Alzheimer’s disease | Study partner/caregiver required | Ph 2 | Completed | 60 | Sep 2017 | 1 | results |
| NCT01278407A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase | Donepezil Lewy body dementia | Dementia with Lewy bodies | Ph 3 | Completed | 56 | Mar 2013 | 2 | results |
| NCT00151398Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD) | Donepezil, Lecozotan Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 56 | Mar 2008 | - | |
| NCT01539031Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease | Donepezil Alzheimer’s disease | Alzheimer's disease | Ph 3 | Completed | 54 | Jan 2015 | - | |
| NCT00630851A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes | Donepezil Alzheimer’s disease | Alzheimer's disease | Ph 3 | Completed | 53 | Oct 2004 | - | |
| NCT00543855A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431) | Donepezil Lewy body dementia | Dementia with Lewy bodies | Ph 2 | Completed | 43 | Feb 2010 | - | results |
| NCT00096473Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease | Donepezil Alzheimer’s disease | Age ≥50 | Ph 3 | Completed | 42 | Jun 2005 | - | |
| NCT00571064The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility | Donepezil Alzheimer’s disease | Alzheimer's disease | Ph 4 | Completed | 36 | Dec 2008 | - | results |
| NCT00230568EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) | Donepezil Alzheimer’s disease | Alzheimer's disease | Ph 4 | Completed | 35 | Apr 2007 | - | |
| NCT00693004Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease | Donepezil, PRX-03140 Alzheimer’s disease | Alzheimer's disease | Ph 2 | Terminated | 33 | Jan 2010 | - | |
| NCT01466088Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD) | AZD3480, Donepezil Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 33 | May 2014 | - | |
| NCT01527916Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease | ABT-126, Donepezil Alzheimer’s disease | mild-to-moderate AD | Ph 2 | Completed | 33 | Nov 2013 | 1 | |
| NCT01404169A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease | Donepezil Alzheimer’s disease | Alzheimer's disease | Ph 3 | Completed | 32 | Jul 2014 | - | |
